Connect with us

Press Release

RWA Summit Hong Kong 2026: The Definitive Bridge Between TradFi and On-Chain Realities

Published

2 weeks ago

on

The RWA Summit Hong Kong has come to an end—an exciting event that has cemented the city’s status as the world’s leading center for real asset tokenization (RWA). These were two intense days when more than 700 carefully curated participants, 50+ distinguished speakers, and 80+ leading institutional investors gathered to map out the future of DePin, stablecoins, and the move toward bringing TradFi on-chain.

Rather than revisiting whether tokenization is viable, discussions focused on how it can be executed within credible legal, financial, and operational frameworks.

“RWA SUMMIT Hong Kong was not just another event for us, it was a place where real deals and business happened. We were proud to co-host the event and bring together potential partners, regulators and market leaders. It’s a great opportunity to present our bonds tokenization and DeFi projects to both TradFi and Digital Assets players. I believe that the key result of any event are the real deals that follow. RWA SUMMIT is definitely this kind of event. No noise, no hype, only real expertise of speakers, and a highly curated network” – Peter Kadish, Managing Director LynxCap Investments, RWA SUMMIT Hong Kong co-host.

“The RWA Summit clearly showed that tokenization has moved beyond theory into execution,” says Scott Thiel, co-founder & CEO of Tokinvest. “Across panels on venture capital, IP tokenization, and institutional adoption, the focus was on infrastructure, liquidity planning, and trusted market frameworks.”

And this is how Gillian Wu, founder and CEO of Mulana Investment Management, comments on the insights of the event: “At the RWA Summit during Consensus Hong Kong, we explored how real-world assets are bringing wealth on-chain through greater efficiency, transparency, disintermediation, and fractionalized ownership. Tokenization, however, does not change the fundamental factors that influence value, and investors must carefully assess counterparty risk and liquidity. Although market fragmentation and structural differences between DeFi, exchanges, and traditional finance remain challenges, progress toward convergence is evident.”

Day 1: Forging Regulatory Pathways and Institutional Momentum

The summit opened with remarks from Joseph Chan, Under Secretary for Financial Services and the Treasury of the Hong Kong Government, who highlighted Hong Kong’s regulatory direction and its ambition to provide clarity for tokenized financial products. The message was consistent throughout the day: regulatory structure is no longer an obstacle but a prerequisite for scale.

The day included four spotlight sessions.

The first one was on global frameworks. The participants got a profound exploration of regional RWA trends, featuring insights from Scott Thiel (Tokinvest), Julian Kwan (InvestaX), and Terence Ng (EX.IO), expertly moderated by Peter Kadish (LynxCap). The takeaway? Regulation has evolved from a barrier into a strategic advantage.

Thereafter, we covered the AI convergence. Alan Lau (Animoca Brands) and Geoff Kot (Standard Chartered) delved into how artificial intelligence is revolutionizing the connection between traditional banking and digital asset ecosystems.

Another essential point was related to banking giants on-chain. Bugra Celik (HSBC) and Giorgia Pellizzari (Hex Trust) highlighted the transition from experimental proof-of-concept to full-scale institutional adoption, emphasizing robust custody and security for digital currencies.

The day concluded with a forward-looking exchange between Nenter Chow of Bitmart and Sébastien Borget of The Sandbox. They explored how crypto-native ecosystems are incorporating RWAs. The conversation centered on sustainable value creation rather than short-term market cycles.

“At the RWA Summit in Hong Kong, we discussed how blockchain is expanding from virtual real estate to collectible assets and user-generated content revenues being tokenized on-chain. The direction is clear: blockchain technology will become broadly adopted across gaming, digital assets, and the creator economy. It will ultimately integrate so seamlessly into user experiences that people benefit from it without needing to think about the underlying infrastructure,” shares Sébastien Borget, co-founder of SandBox & SandChain.

The first day also featured an outstanding lineup of industry leaders and innovators, including Cathal Donnellan, President at NexStox; Marcos Chow, Group CIO at HKT; Rocky Mui, Partner at Clifford Chance; Tom Wan, Partner at Imprint Capital Partners; Neil Tan, Managing Partner at Tsunami Advisors and Chairman of the AI Association of Hong Kong; Phillip Pon, CEO at EMURGO; Andrei Grachev, Managing Partner at DWF Labs; Musheer Ahmed, Founder & CEO at FinStep Asia; Jelena Zhang, SVP at Amber Premium; Jayendra Jog, Co-Founder at Sei Labs; Nikita (Sachdev) Lord, Founder & CEO at Luna PR; Edwin Mata, Co-Founder & CEO at Brickken; Preetam Rao, Co-Founder & CEO at QuillAudits; and Leo Fan, Founder & CEO at Cysic.

Day 2: Envisioning Tomorrow’s Wealth, IP, and Payment Innovations

The second day shifted toward applied use cases, examining how tokenization is reshaping wealth management, intellectual property, and payment systems.

The second day of RWA Summit opened with a high-level fireside chat featuring Sean McHugh, Senior Director – Market Assurance at VARA (Virtual Assets Regulatory Authority). The discussion set the tone for the day, focusing on regulatory clarity, market integrity, and the evolving framework for virtual assets in the region.

In a fireside discussion, Yat Siu of Animoca Brands and Bowie Lau of MaGE Group analyzed the implications of IP tokenization for content platforms and creator economies for giants like YouTube, Spotify, and Netflix. The conversation focused on whether blockchain-based models can provide more direct monetization and ownership structures while maintaining compliance and investor protections.

“A recurring theme in our discussion was that RWA is not about “putting a single asset on-chain”; it’s about modernizing financial infrastructure without breaking law, trust, or market structure,” comments Jeffrey Broer, venture advisor at Kohpy Ventures. “Tokenization within a regulated environment does not automatically create liquidity, and lower minimums do not mean retail access. True liquidity requires credible market design and participation. For venture-backed startups, the real opportunity lies in compliance-native infrastructure, settlement and orchestration layers, custody, risk tooling, and transparency rails. In short, the value is in building the plumbing, not chasing product hype.”

Wealth migration onto blockchain infrastructure was addressed by Ray Tam of Revo Digital Family Office and Florian M Spiegl of Evident Capital. They tackled the hurdles of onboarding professional investor (PI) wealth onto the blockchain while unveiling exciting avenues for retail investors.

The next spotlight session of the day was on the PayFi Revolution. Rita Liu (RD Technologies) and Evan Auyang (Animoca Brands) offered a grounded perspective on stablecoins and payment finance in the “Asian Reality.”

The 2-day event concluded with a comparative discussion featuring Pauline Fan of InvestHK, Rachel Lee of Cyberport, and Irina Heaver of RWA Labs. The panel assessed Hong Kong’s regulatory agility against competitors like the UAE and beyond.

The stage then welcomed an exceptional lineup of investors, founders, and industry leaders, including Noah Frankel, Investment Analyst at JSquare; Tobias Bauer, General Partner at TBV; Calvin Ng, General Partner at Plutus VC; Melody He, Co-Founder & Partner at Spartan Group; Craig Dyer, Head of Capital Markets at HECTO; Pauli Speaks, CBDO at Cryptic; DiZien Low, Director of Business Development at Polygon Labs; Jacky Kong, Head of Hong Kong at Ava Labs; Sonia Shaw, CEO at OneAsset; Andrey Fedorov, CMO & CBDO at STON.fi; Jackee Wong, Partner & CMO at Leadsourcing; Sudeep Mehta, COO at STBL; and Lawrence Tsui, Director of Business Development and Strategic Solutions for Hong Kong & Mongolia at Fortinet.

Special thanks to the partners of RWA Summit, in particular our Strategic Partner, BTSE Enterprise Solutions, and our Partner, STON.fi, for their invaluable support and contribution to the event’s success.

Industry Developments and Expansion

Apart from panel discussions, the summit also provided a platform for industry announcements. LynxCap introduced its DeFi platform designed to connect RWA yield strategies with structured liquidity environments. In parallel, Ivan V. Ivanov of UVECON.VC and Irina Heaver of RWA Labs announced the launch of Dubai RWA Week 2026, signaling increased collaboration between Asian and Middle Eastern tokenization hubs.

“RWA Summit Hong Kong brought together strong voices from both TradFi and digital assets,” says Ivan V. Ivanov, founder of RWA Summit. “The discussions focused on execution, regulation, and real market structure and were grounded in actual cases, not theory.

What stood out to me most was the growing alignment between ecosystems like Hong Kong and Dubai. Different frameworks—and clear potential for collaboration. Our goal was to create a platform where real experts share real cases, challenges, and practical paths forward. Judging by the depth of discussion, we are clearly moving in the right direction.”

To sum it up, the RWA Summit Hong Kong 2026 has unequivocally demonstrated that the dialogue has advanced from “Is this feasible?” to “How swiftly can we expand?” By bridging TradFi’s regulatory rigor with DeFi’s tech stack, we’re moving toward a financial system that is actually transparent and accessible, not just fast.

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Related Topics:
Continue Reading

Press Release

CMS(867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity

Published

31 minutes ago

on

March 5, 2026

By

SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that self-developed innovative drug INHBE-targeting small nucleic acid drug CMS-D008 injection (“CMS-D008”) received the Drug Clinical Trial Approval Notice issued by National Medical Products Administration (“NMPA”) on 4 March 2026. The NMPA has approved the conduct of clinical trials of CMS-D008 injection for overweight or obese individuals.

About CMS-D008

CMS-D008 is a novel siRNA therapy administered by subcutaneous injection. CMS-D008 targets and reduces the hepatic expression of the inhibin subunit beta E (INHBE) gene and lowers the level of Activin E protein encoded by INHBE, which blocks Activin E-ALK7 signaling and reduces fat accumulation effectively. Preclinical studies suggested that CMS-D008 efficiently and sustainably suppressed INHBE expression. In the diet-induced obesity model, CMS-D008 enhanced weight loss by reducing fat mass while retaining lean mass with a good safety profile. It demonstrates potentially better prospects for high-quality, long-term weight loss that boosts fat-specific loss while preserving muscle mass. In the future, it may be developed for the treatment of overweight/obesity, abdominal obesity, and related metabolic diseases.

Fat Loss, muscle preserved: a potentially better therapeutic option for overweight/obesity

Overweight or obesity is a chronic, progressive, relapsing disease characterized by excessive accumulation or abnormal distribution or function of body fat[1]. World Obesity Atlas 2025 Report projected that the global proportion of overweight and obese adults will rise to 50%, with nearly 3 billion adults impacted by high body mass index (BMI), and the population of adults who are overweight or obese in China is projected to reach 515 million by 2030[2]. Existing GLP-1RAs have been proven to be effective for the treatment of overweight and obesity. The main actions of GLP-1RAs are to suppress appetite by acting on the central nervous system and to delay gastric emptying[3]. INHBE’s novel mechanism of action differs from GLP-1RAs. INHBE is identified through genome-wide association studies. Populations with loss of function in INHBE are associated with favorable fat distribution and beneficial metabolic characteristics[4]. Targeted inhibition of INHBE might be more conducive for long-term weight management at the genetic level with precisely lower visceral fat and favorable metabolic profiles.

CMS-D008 teams up with CMS-D005: highly effective weight loss plus long-term maintenance, building a more comprehensive weight-loss solution

CMS-D008 will synergize with CMS-D005, a self-developed innovative drug currently in clinical development. CMS-D008 reduces fat without sacrificing muscle mass by precisely inhibiting INHBE gene expression; while CMS-D005, as a GLP-1R/GCGR dual agonist, can effectively reduce liver fat while losing weight. The synergy between these two drugs will achieve highly effective weight loss benefits and long-term maintenance of results, jointly enhancing the Group’s R&D capabilities and product competitiveness in the field of obesity/metabolic treatment. Furthermore, leveraging the Group’s mature network resources in the field of cardiovascular and metabolic diseases, the drug’s R&D and commercialization process will be accelerated, providing patients with more comprehensive and innovative treatment options.

The Group is actively preparing to initiate relevant clinical trials and strives to launch the Product as soon as possible.

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.

Reference:

  1. Chinese Society of Endocrinology. Guideline for chronic weight management and clinical practice of anti-obesity medications(2024 version). Chinese Journal of Endocrinology and Metabolism. 2024,40(7):545-564.
  2. World Obesity Federation. World Obesity Atlas 2025. London: World Obesity Federation, 2025. https://data.worldobesity.org/publications/?cat=23
  3. Zhikai Zheng, Yao Zong, Yiyang Ma, Yucheng Tian, Yidan Pang, Changqing Zhang, Junjie Gao. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Sig Transduct Target Ther 9, 234 (2024). doi: 10.1038/s41392-024-01931-z
  4. Parsa Akbari, Olukayode A Sosina, Jonas Bovijn, et al. Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes. Nat Commun.2022 Aug 23;13(1):4844. doi: 10.1038/s41467-022-32398-7.

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Email: ir@cms.net.cn

Website: https://web.cms.net.cn/en/home/

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Oberheiden P.C. Now Offering Nevada Asset Protection Trusts

Published

47 minutes ago

on

March 5, 2026

By

United States, 5th Mar 2026 – Oberheiden P.C. is pleased to announce that the firm’s asset protection attorneys are now offering Nevada asset protection trusts to clients nationwide. Nevada asset protection trusts are unique among domestic asset protection trusts (DAPTs) for their flexibility, and they can be powerful tools for insulating high-net-worth individuals’ assets from creditor claims both in and out of court.

According to the firm’s founding attorney, Dr. Nick Oberheiden, “While many high-net-worth individuals are familiar with the benefits afforded by offshore asset protection trusts, far fewer are familiar with the domestic options that are available. The Nevada asset protection trust can be a particularly good option for individuals who want to protect their assets within the United States while also taking advantage of the estate planning, tax planning, and other benefits that domestic trusts can afford.”

Dr. Oberheiden says that forming Nevada asset protection trust can be a particularly good option for several reasons. For example, while a Nevada asset protection trust is a type of irrevocable trust, a grantor (the individual who forms a trust) still has the ability to modify how they hold their assets over time. This distinguishes Nevada law from the laws of many other states. Nevada also has a shorter statute of limitations for creditor claims than most other states (two years in most cases), and Nevada law does not recognize any exception creditors.

“These factors, combined with the relative ease of forming a Nevada domestic asset protection trust, make using a Nevada DAPT a desirable option in a wide range of circumstances—including circumstances in which high-net-worth individuals might otherwise be looking at transferring assets into an offshore trust established in the Cook Islands or another foreign jurisdiction.” Dr. Oberheiden continues, “If you are interested in learning about your options for protecting your wealth from both known and unknown creditors, it will be worth talking to an attorney about whether a Nevada DAPT is a good option for your individual circumstances.”

While forming a Nevada DAPT involves leveraging the benefits afforded under the state’s trust laws, Dr. Oberheiden emphasizes that this is not solely an option for Nevada residents. “When the Nevada legislature adopted the state’s asset protection trust laws, it specifically opened up the possibility of forming a Nevada DAPT to individuals residing across the country. Although there are certain statutory requirements that make it important to work with a Nevada trust company, individuals nationwide can form statutory trusts in Nevada for asset protection purposes.”

Dr. Oberheiden is also quick to emphasize that while forming a Nevada DAPT is a desirable option in many cases, it is important for all high-net-worth individuals to make informed decisions about their asset protection needs based on their individual circumstances. “While forming a Nevada DAPT to protect real property and other assets will make sense for many individuals, it is important to consider the other options that are available as well. A few states offer self-settled spendthrift trust options that will meet individuals’ needs in some cases; and, in other cases, forming an offshore asset protection trust may be necessary to protect assets located around the world.”

“Additionally,” he continues, “limited liability companies and other vehicles can be used for asset protection as well. Purchasing liability insurance can be a cost-effective means of limiting high-net-worth individuals’ personal liability exposure as well. Ultimately, while we are now offering Nevada asset protection trusts, we are still focused on ensuring that we provide each of our clients with a custom-tailored solution focused on their specific risks and needs.”

Dr. Oberheiden says that high-net-worth individuals who are interested in learning about the options for safeguarding their assets in the U.S. and abroad are encouraged to contact the firm for a complimentary initial consultation. “We have a team of highly skilled asset protection attorneys who are committed to helping our clients protect their assets not only in the short term, but also for future generations.” He continues, “If you have questions, one of our attorneys will be more than happy to schedule a call to begin talking through your options in strict confidence.”

Nick Oberheiden, Founding Attorney, 888-680-1745 (Office)

Attorney Advertising – Oberheiden, P.C., is an asset protection law firm headquartered in Houston, TX with a nationwide network of senior attorneys and consultants. The firm’s asset protection attorneys are available to assist clients with Nevada asset protection trusts and other asset protection strategies throughout the United States. The firm’s addresses and contact information can be found at www.federal-lawyer.com/our-locations.

 

Media Contact

Organization: Oberheiden, P.C.

Contact Person: Nick Oberheiden, Founding Attorney

Website: https://federal-lawyer.com/asset-protection/

Email: Send Email

Contact Number: +18886801745

Country:United States

Release id:42208

Disclaimer: This press release is provided for general informational purposes only and does not constitute legal, financial, or professional advice.

The post Oberheiden P.C. Now Offering Nevada Asset Protection Trusts appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

SPL VPN Announces AI-Driven Architectural Shift to Replace Manual Server Routing

Published

1 hour ago

on

March 5, 2026

By

Dubai, UAE, 5th March 2026, ZEX PR WIRE, SPL VPN has announced an architectural transition to an AI-driven routing engine, effectively automating global server selection for its two million users. The shift replaces traditional manual configurations with a proprietary protocol designed to eliminate connection guesswork and latency issues.

As digital privacy requirements evolve, SPL VPN is prioritizing usability through a system that analyzes network congestion, ISP throttling, and packet loss in real-time. This “zero-touch” approach automatically builds optimized routes for specific traffic types, such as streaming or secure browsing, without user intervention.

The update features predictive reconnection technology, allowing the infrastructure to anticipate node failures and switch paths before a connection drop occurs. This technical advancement is reflected in the platform’s new adaptive interface, which simplifies the experience for over 500,000 daily active users by removing legacy server lists.

“The future of connectivity is a seamless layer that functions before the user identifies a need for it,” stated the Head of Product at SPL. “After eight years of development, we are moving beyond the industry’s traditional ‘server-count race’ toward a model of delivery intelligence.”

Established in 2018, SPL VPN has consistently combined encryption standards with emerging AI research. This latest expansion strengthens the company’s position as a utility-focused provider for the modern web, offering a faster and more intuitive framework for global digital security.

About SPL VPN

SPL VPN is a global provider of digital privacy solutions. Established in 2018 in Singapore, the company utilizes AI-driven routing and military-grade encryption to provide secure, high-performance internet access for over 2 million users worldwide.

Website: https://splvpn.com/

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST

Like Us
Follow Us
Subscribe Us
Follow Us